Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N03 ANTIEPILEPTICS
N03A ANTIEPILEPTICS
N03AX Other antiepileptics
N03AX17 Stiripentol
D05928 Stiripentol (JAN/USAN/INN) <JP>
USP drug classification [BR:br08302]
Anticonvulsants
Anticonvulsants, Other
Stiripentol
D05928 Stiripentol (JAN/USAN/INN)
Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
11 Agents affecting central nervous system
113 Antiepileptics
1139 Others
D05928 Stiripentol (JAN/USAN/INN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG03199 Antiepileptic agent
D05928 Stiripentol
Metabolizing enzyme substrate
DG01892 CYP1A2 substrate
D05928 Stiripentol
DG01639 CYP2C19 substrate
D05928 Stiripentol
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
D05928 Stiripentol
Metabolizing enzyme inhibitor
DG01634 CYP1A2 inhibitor
D05928 Stiripentol
DG01643 CYP2C9 inhibitor
D05928 Stiripentol
DG01933 CYP2C19 inhibitor
D05928 Stiripentol
DG01645 CYP2D6 inhibitor
D05928 Stiripentol
DG02852 CYP3A/CYP3A4 inhibitor
DG01522 CYP3A4 inhibitor
D05928 Stiripentol
Drug classes [BR:br08332]
Neuropsychiatric agent
DG03199 Antiepileptic agent
D05928 Stiripentol
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D05928
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D05928
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D05928
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D05928
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D05928